Centre for Nuclear Medicine

Centre for Nuclear Medicine

Linear Accelerator

Linear AcceleratorLinear AcceleratorLinear Accelerator

Linear AcceleratorLinear Accelerator

On 14thJune 2024, Dr. Sudeep Gupta, Director – TATA Memorial Centre, inaugurated ‘Nuclear Medical Centre’ for cancer diagnosis and treatment in a grand ceremony at B. K. L. Walwalakar Hospital and Medical College; Srishetra – Dervan. On this occasion, Ms. Riddhi Bhatia, Mr. Yogesh Karmarkar, representatives of Kotak Mahindra Bank, who has given huge financial support to this centre; Ms. Chitra and Ms. Hemadri Buzruk of Rama- Purushottam Trust, Officers of Nana Palkar Trust, Dr. Shripad Banavali, Director (Academic), Tata Memorial Centre, Mumbai; Executive Trustee of Vitthalrao Joshi Charities Trust Shri. Vikasrao Walawalkar and Chief Trustee, Shri. Ashokrao Joshi, Medical Director of Dervan Hospital Dr. Suvarna Patil, Dean of, B.K.L. Walawalkar.

Medical College Dr. Mansingh Ghatage, Dr. Rita Mulherkar, and much more dignitaries, faculty, staff, students and locals were present. Chief Guest Dr. Sudeep Gupta and his wife Dr. Sumedha Gupta, including the guests of honor, had reached Dervan the evening before. All of them were given a tour of the medical college, and in the college’s conference hall, Dr. Suvarna Patil gave an elaborate presentation to the guests about the philanthropic work that the Trust undertakes in a variety of fields. Each guest took an interested look around the hospital. The “Nuclear Medicine Centre,” which is 6500 square feet in size and features PET and SPECT facilities in addition to high and low doses of nuclide therapy, is being inaugurated today; in a recently built multi-storey structure. Every structure, including walls, floors, and ceilings, etc. are 230 mm, as advised by the AERB, made of substantial reinforced concrete. 6.10 X 7.5 m for SPECT and PET imaging. Size rooms have been built with a separate electrical room, radio pharmacy, dose administration room, waiting area, safe radioactive waste storage system, and separate room for radioactive material storage. Attached labs are also included. Here, the heart’s muscle strength is also assessed through a “stress test.” A separate room has been set up for patients receiving high dose therapy. According to AERB standards, two 6000-liter tanks are constructed for contaminated miles. The people of Konkan will be benefitted from PET-CT ScanF-18, FDGF-18, PSMAF-18, Cardiac Viability, and SPECT Scan for Renal, Cardiac, Liver, Bone, Thyroid, GE Reflux, Lung Perfusion scan, lodine therapy for thyroid disorders etc.

MBBS Students Visit to Centre for Nuclear Medicine

Linear Accelerator

Linear AcceleratorLinear Accelerator

Linear AcceleratorLinear Accelerator

List of Test

Sr. No. Test name OPD/ IPD Indication
1 F-18 FDG PET CT (CECT) OPD Benign & Malignant tumors
2 F-18 FDG PET CT ( NCCT) OPD Benign & Malignant tumors with elevated serum creatinine, sarcoma, lymphoma
3 Cardiac FDG PET CT: OPD viability
4 F-18 DOPA PET CT OPD Brain tumors, epilespy ,etc
5 PSMA PET CT OPD Ca prostate
6 SSR PET CT OPD NET
7 Myocardial perfusion imaging (MPI)-MIBI scan OPD Viability
Rest OPD
Stress
8 Pertechnetate Thyroid scintigraphy OPD Graves disease & Thyroiditis
9 Bone scintigraphy OPD Benign & Malignancy, cellulitis, osteomylittis
10 Three Phase bone scan
11 Parathyroid scintigraphy OPD Adenoma, Hyperplasia
12 DTPA scan OPD Obstructive Uropathy
13 DMSA scan OPD Infections, Absolute Function
14 EC scan OPD MRD, Renal Failure
15 Lung Perfusion OPD Pulmonary embolism
16 Radioiodine scan OPD Post Thyroidectomy
17 m-IBG Scan OPD Pheochromocytoma and neuroblastomas.
Therapy Procedures
18 Radioiodine therapy (Low dose 10 mci) OPD Grave’s disease
(Low dose 15 mci) OPD Grave’s disease
19 Radioiodine therapy (High Dose) 50 mCi Indoor stay Papillary Carcinoma
100 mCi Indoor stay Papillary Carcinoma with nodal mets
150 mCi Indoor stay Papillary Carcinoma with lung mets Follicular carcinoma
200 mCi Indoor stay
250 mCi Indoor stay
20 PRRT(Lu-177) DOTA TATE therapy 100 mCi Day care CRPC
200 mCi Day care
PRRT(Lu-177) PSMA therapy 100 mCi Day care Ca prostate
200 mCi Day care
21 m-IBG therapy 100 mCi Indoor stay pheochromocytoma and neuroblastomas.